VIVO
Weill Cornell Medical College
Index
Log in
Search form
Home
People
Organizations
Research
Support
Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Innovative Dosing Schedules of AmBisome for Treatment of Experimental Invasive Pulmonary Aspergillosis: Establishing a Preclinical Foundation for Improved Patient Care and Outcome
Grant
Overview
date/time interval
July 1, 2022 - February 22, 2024
awarded by
Gilead Sciences, Inc.
administered by
Medicine-Infectious Diseases
sponsor award ID
SRA 223608-01